Medpace Investors, LLC

Medpace Investors, LLC discloses dealings in Medpace Holdings, Inc. to SEC (Form 4). Over a trading history stretching from 15 June 2021 to 6 March 2024, the count stands at 65 filings.

The open-market side counts 10 purchases for €80.8M alongside 55 sales for €329.0M. On balance, insiders were net sellers of €248.3M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2024: no purchases and 7 sales on the market.

A typical purchase (the median) is worth €9.0M. Clusters matter here: 10 out of 10 purchases overlapped with buying by a colleague within 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

The latest filing, published on 8 March 2024, reports an open-market sale of €38.0M in Medpace Holdings, Inc. The clock since the last published purchase (23 September 2022) now reads 1,486 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.